Ending ALS together, worldwide
Answer ALS (answerals.org) scores 70 out of 100 on Brand Analyzer, placing it in the Developing tier among Healthcare brands, Non-profit brands, Education brands, in the 22nd percentile of 13662 Healthcare brands.
Answer ALS is a nonprofit clinical research initiative dedicated to ending ALS (amyotrophic lateral sclerosis) through what it describes as the world's largest coordinated and collaborative ALS research project. It unites independent research projects, pharmaceutical partners, and academic institutions through an open-access data platform called Neuromine, sharing data, biosamples, and iPSCs. It serves ALS patients and families, researchers, academic institutions, pharmaceutical companies, and donors, operating primarily in the healthcare, non-profit, and education sectors.
| Brand Name | Answer ALS |
|---|---|
| Domain | answerals.org |
| Industry | Healthcare, Non-profit |
| Main Competitors | ALS Association (76/100), Project MinE (79/100), Target ALS (78/100), ALS Therapy Development Institute (86/100), Northeast ALS Consortium (NEALS) (79/100), Muscular Dystrophy Association (84/100) |
Moz Domain Authority 39/100 vs category average 41 / leader 95 - limited third-party links, so AI systems rarely encounter mentions of the brand.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "Answer ALS is committed to ending ALS by driving the world's largest coordinated and collaborative ALS research project." (No meta description) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: Microdata (Schema.org), canonical. Adding Organization and FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Detected tech stack: WordPress, Ghost.
Social footprint: verified profiles on Facebook, Instagram, X (Twitter), LinkedIn, YouTube, GitHub - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Live results from asking a general-purpose AI assistant about the brand, checked October 2026.
When asked "What is Answer ALS?", Claude could identify the brand as of October 2026. Answer ALS is a large-scale collaborative research program that collects clinical, genetic, and biomarker data from ALS patients to build a comprehensive open-access dataset for researchers studying the disease. Best known for Creating one of the largest open-access ALS patient data and biosample repositories to accelerate research into the disease's causes and treatments.
When asked "Best brands similar to Answer ALS?", Claude would recommend Answer ALS as of October 2026. It's a well-regarded research initiative in the ALS space that researchers and patient advocates often cite for its data-sharing model.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
Answer ALS's main competitors in Healthcare: ALS Association (76/100), Project MinE (79/100), Target ALS (78/100), ALS Therapy Development Institute (86/100), Northeast ALS Consortium (NEALS) (79/100).
Sources: Brand Analyzer scan
Answer ALS has limited AI-search visibility, scoring 25/100 on Brand Analyzer's AI visibility composite (visibility 13, trust 26, recommendation 45). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: Answer ALS official site
Answer ALS scores 45/100 on Brand Analyzer's AI recommendation signal, indicating it is less likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
Sources: Answer ALS official site
Answer ALS is a nonprofit clinical research initiative focused on ending ALS (amyotrophic lateral sclerosis). It describes itself as driving the world's largest coordinated and collaborative ALS research project, bringing together researchers, academic institutions, pharmaceutical companies, and patient communities under a shared, open-access research framework.
Sources: Answer ALS official site
Answer ALS coordinates a large-scale, collaborative ALS research effort that unites hundreds of independent research projects, pharmaceutical partnerships, and academic collaborations. It provides open-access data, biosamples, and induced pluripotent stem cells (iPSCs) through its platform, Neuromine, enabling researchers worldwide to study ALS and work toward finding treatments and a cure.
Sources: Answer ALS official site
Answer ALS can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: Answer ALS official site
Answer ALS offers open-access research data, biosamples, and induced pluripotent stem cells (iPSCs) to the scientific community through its platform, Neuromine. It also facilitates collaborative research projects involving academic institutions and pharmaceutical partners aimed at understanding and treating ALS.
Sources: Answer ALS official site
Answer ALS is used by ALS patients and their families, medical and academic researchers, academic institutions, pharmaceutical companies, and donors who support ALS research and are invested in finding a cure for the disease.
Sources: Answer ALS official site
Answer ALS is known for running what it calls the world's largest coordinated and collaborative ALS research project, and for creating Neuromine, an open-access data platform that shares ALS research data, biosamples, and iPSCs with the global scientific community.
Sources: Answer ALS official site
Answer ALS scores 25/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
Answer ALS has a weak AI-visibility profile at 25/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (45/100) and its weakest is visibility (13/100). It benefits from a Wikidata knowledge-graph entry and open access for AI crawlers (GPTBot, ClaudeBot, etc.). The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data, a low Moz Domain Authority of 39/100 and thin schema.org structured data. In a live check, Claude could already identify Answer ALS from memory (October 2026) - a sign these signals are paying off.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to Answer ALS: Anetic Aid (70/100), Amparo Saúde (70/100), Apotal (70/100), The Arbor Company (70/100).
A step up - brands to learn from: ZT Corporate (71/100), Zorgnet-Icuro (71/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.